Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;7(6):560-575.
doi: 10.1016/S2468-1253(22)00004-8. Epub 2022 Apr 13.

Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver

Affiliations
Review

Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver

Samuel Shribman et al. Lancet Gastroenterol Hepatol. 2022 Jun.

Abstract

Wilson's disease is an autosomal-recessive disorder of copper metabolism with hepatic, neurological, psychiatric, ophthalmological, haematological, renal, and rheumatological manifestations. Making a diagnosis can be challenging given that no single test can confirm or exclude the disease, and diagnostic delays are common. Treatment protocols vary and adverse effects, including paradoxical neurological worsening, can occur. In this Review, we provide a practical guide to the diagnosis of Wilson's disease. We include recommendations on indications for testing, how to interpret results, and when additional investigations are required. We also cover treatment initiation, ideally under the guidance of a specialist centre for Wilson's disease, and the principles behind long-term management. This guidance was developed by a multidisciplinary group of Wilson's disease experts formed through the British Association for the Study of the Liver. The guidance has been endorsed by the British Society of Gastroenterology and approved by the Association of British Neurologists.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests SS has received grants from the Guarantors of Brain via the Association of British Neurologists and Wilson's Disease Support Group UK. AA has received grants from Alexion Pharmaceuticals, Orphalan UK, and Univar Solutions, is on advisory boards for Alexion Pharmaceuticals, Orphalan UK, Ultragenyx, Univar Solutions and ViVet, is on the speakers bureau for Orphalan UK and Univar Solutions, and is a co-applicant on a patent for bis-choline tetrathiomolybdate. AD has received consulting fees and payments from Alexion Pharmaceuticals and Univar Solutions and is on the advisory boards for Univar Solutions, Alexion Pharmaceuticals, and Orphalan UK. DK has received consulting fees from Orphalan UK. TTW is president of the Association of British Neurologists. WG has received consulting fees for Jnana Therapeutics. OB has received a grant from the Wilson's Disease Support Group UK and is chair of the Movement Disorders Advisory Group at the Association of British Neurologists. All other authors declare no competing interests.

Comment in

Publication types

LinkOut - more resources